Lacticaseibacillus paracasei (formerly Lactobacillus paracasei) is a probiotic species found naturally in the human gut, fermented foods, and dairy products. Reclassified in 2020 from Lactobacillus to the new genus Lacticaseibacillus. NO GRADED OUTCOMES - research is strain-specific and scattered. Various strains have been studied for immune function, allergies, oral health, and gut health. Effects are highly strain-dependent - L. paracasei is a species, and different strains (like L. paracasei Lpc-37 or L. paracasei Shirota) may have different effects. Generally safe as a probiotic.
Lacticaseibacillus paracasei (formerly Lactobacillus paracasei) is a probiotic species found naturally in the human gut, fermented foods, and dairy products. Reclassified in 2020 from Lactobacillus to the new genus Lacticaseibacillus.
Best grade per condition (each condition may have multiple outcomes)
2 shared conditions · 304 outcomes
Spirulina, commonly known as “blue-green algae”, is a nontoxic cyanobacterium that is rich in various nutrients and bioactive pigments and polyphenols. Spirulina contains many antioxidant compounds and could have beneficial cardiometabolic effects.
2 shared conditions · 215 outcomes
Probiotics are microorganisms that can have a positive effect on health.
2 shared conditions · 248 outcomes
Magnesium is an essential dietary mineral that is involved in energy production, nervous system function, blood pressure regulation, and blood glucose control. A lack of magnesium in the diet — which is common in modern societies — is associated with an increased risk of diabetes, cardiovascular disease, and other health conditions.
2 shared conditions · 6 outcomes
Higenamine (Norcoclaurine) is a beta-2 adrenergic agonist from the Nandina plant, marketed as a fat burner with similar mechanisms to ephedrine. REGULATORY WARNING: On FDA Dietary Supplement Ingredient Advisory List since April 2019 - not considered a lawful dietary supplement ingredient. NO GRADED OUTCOMES - very limited human research. May have bronchodilator effects (anti-asthmatic) and theoretical fat-burning effects via beta-2 agonism. Also WADA-banned substance in competitive sports. The similarity to ephedrine (a banned stimulant) and lack of human safety data makes this a concerning supplement. Not recommended due to regulatory status and insufficient evidence.
2 shared conditions · 7 outcomes
Artemisia iwayomogi (Haninjin) is a Korean herb in the mugwort/wormwood family with limited traditional use but emerging preclinical research. NO GRADED OUTCOMES - only animal and in vitro studies exist. May have anti-allergic, anti-obesity (PPARδ activation), and anti-cancer properties based on preliminary research. Contains sesquiterpenes, flavonoids, and coumarins. NOT to be confused with other Artemisia species (A. annua for malaria, A. absinthium for absinthe). Human evidence is completely lacking - research is too preliminary for any recommendations.
2 shared conditions · 448 outcomes
Fish oil is a mix of mostly EPA and DHA derived from fatty fish. It reduces triglycerides, but does not seem to affect the rate of cardiovascular events. It appears to reduce the symptoms of depression and improve some painful, inflammatory conditions.
2 shared conditions · 189 outcomes
CLAs are fatty acids that acts on a system known as PPAR to induce fat loss. At least, that is what the theory says. CLA too weakly affects PPAR receptors to really induce fat loss in an appreciable amount. TTA appears more promising.
2 shared conditions · 68 outcomes
Coleus forskohlii is an Ayurvedic herb. Extremely limited research suggests that forskolin, the plant’s main bioactive compound, may reduce intraocular pressure and asthma symptoms, increase testosterone and bone mineral density, and improve metabolic health and body composition.